Asymmetric Dimethylarginine and Its Relation as a Biomarker in Nephrologic Diseases

Volume: 11, Pages: BMI.S38434 - BMI.S38434
Published: Jan 1, 2016
Abstract
It is encouraging to observe that a search for publications on “asymmetric dimethylarginine (ADMA)” in PubMed, as updated on June 2016, yielded >2500 items, 24 years after a splendid paper published by Vallance et al in which the authors proposed that ADMA accumulation could be a cardiovascular risk factor in chronic kidney diseases. ADMA is the endogenous inhibitor of nitric oxide synthase and is related to endothelial dysfunction, which...
Paper Details
Title
Asymmetric Dimethylarginine and Its Relation as a Biomarker in Nephrologic Diseases
Published Date
Jan 1, 2016
Volume
11
Pages
BMI.S38434 - BMI.S38434
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.